Vina Churdboonchart

507 total citations
17 papers, 264 citations indexed

About

Vina Churdboonchart is a scholar working on Infectious Diseases, Virology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Vina Churdboonchart has authored 17 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 9 papers in Virology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Vina Churdboonchart's work include HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (8 papers) and HIV/AIDS Research and Interventions (7 papers). Vina Churdboonchart is often cited by papers focused on HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (8 papers) and HIV/AIDS Research and Interventions (7 papers). Vina Churdboonchart collaborates with scholars based in Thailand, United States and Malaysia. Vina Churdboonchart's co-authors include Natth Bhamarapravati, Sayomporn Sirinavin, Wasun Chantratita, Montip Tiensuwan, Chonlaphat Sukasem, Prasit Futrakul, Worachart Sirawaraporn, Sanchai Chasombat, Dennis J. Carlo and Sungwal Rugpao and has published in prestigious journals such as The Lancet, Journal of Clinical Microbiology and AIDS.

In The Last Decade

Vina Churdboonchart

16 papers receiving 254 citations

Peers

Vina Churdboonchart

VIROL

PHEOH

EPIDE

IMMUN

E. Counillon France

Ranjit Warrier United States

Aisling Vaughan United Kingdom

Massimo Di Pietro Italy

Noemia S. Lima United States

Mohamadou Niang France

Hanne Andersen Elyard United States

Anangisye Malabeja Tanzania

Chia Yin Lee Singapore

Fernando Samuel Sion Brazil

E. Counillon France

Vina Churdboonchart

145 ×0.7

48 ×0.4

VIROL

50 ×0.5

PHEOH

69 ×1.6

EPIDE

34 ×1.2

IMMUN

Citations per year, relative to Vina Churdboonchart Vina Churdboonchart (= 1×) peers E. Counillon

Countries citing papers authored by Vina Churdboonchart

Since Specialization

Citations

This map shows the geographic impact of Vina Churdboonchart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vina Churdboonchart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vina Churdboonchart more than expected).

Fields of papers citing papers by Vina Churdboonchart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vina Churdboonchart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vina Churdboonchart. The network helps show where Vina Churdboonchart may publish in the future.

Co-authorship network of co-authors of Vina Churdboonchart

This figure shows the co-authorship network connecting the top 25 collaborators of Vina Churdboonchart. A scholar is included among the top collaborators of Vina Churdboonchart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vina Churdboonchart. Vina Churdboonchart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Sukasem, Chonlaphat, et al.. (2008). Genotypic resistance profiles in antiretroviral-naive HIV-1 infections before and after initiation of first-line HAART: impact of polymorphism on resistance to therapy. International Journal of Antimicrobial Agents. 31(3). 277–281. 26 indexed citations

Sukasem, Chonlaphat, Vina Churdboonchart, Suda Riengrojpitak, et al.. (2007). Genotypic Resistance Mutations in Treatment-Naïve and Treatment-Experienced Patients under Widespread Use of Antiretroviral Drugs in Thailand: Implications for Further Epidemiologic Surveillance. Japanese Journal of Infectious Diseases. 60(5). 284–289. 21 indexed citations

Sukasem, Chonlaphat, et al.. (2007). Prevalence of Antiretroviral Drug Resistance in Treated HIV-1 Infected Patients: Under the Initiative of Access to the NNRTI-Based Regimen in Thailand. Journal of Chemotherapy. 19(5). 528–535. 10 indexed citations

Sukasem, Chonlaphat, Vina Churdboonchart, Sanchai Chasombat, et al.. (2007). Surveillance of Genotypic Resistance Mutations in Chronic HIV-1 Treated Individuals After Completion of the National Access to Antiretroviral Program in Thailand. Infection. 35(2). 81–88. 18 indexed citations

Chantratita, Wasun, et al.. (2004). Delayed progression to AIDS in volunteers treated with long‐term HIV‐1 Immunogen (REMUNE®) therapy in Thailand. HIV Medicine. 5(5). 317–325. 13 indexed citations

Churdboonchart, Vina, et al.. (2001). Long-Term Follow-Up of HIV-1–Infected Thai Patients Immunized with Remune Monotherapy. HIV Clinical Trials. 2(5). 391–398. 6 indexed citations

Churdboonchart, Vina, Verapol Chandeying, Sungwal Rugpao, et al.. (2000). A Double-Blind, Adjuvant-Controlled Trial of Human Immunodeficiency Virus Type 1 (HIV-1) Immunogen (Remune) Monotherapy in Asymptomatic, HIV-1-Infected Thai Subjects with CD4-Cell Counts of >300. Clinical and Diagnostic Laboratory Immunology. 7(5). 728–733. 16 indexed citations

Churdboonchart, Vina, Ronald B. Moss, Worachart Sirawaraporn, et al.. (1998). Effect of HIV-specific immune-based therapy in subjects infected with HIV-1 subtype E in Thailand. AIDS. 12(12). 1521–1527. 12 indexed citations

Churdboonchart, Vina, Ronald B. Moss, Worachart Sirawaraporn, et al.. (1998). Safety and immunogenicity of REMUNE™ in HIV-infected Thai subjects. Vaccine. 16(2-3). 142–149. 14 indexed citations

10.

Ablashi, D. V., Louise G. Chatlynne, William Lapps, et al.. (1998). HUMAN HERPESVIRUS-8 (HHV-8) COMPARATIVE SERO-PREVALENCE IN U.S.A., INDIA, THAILAND, MALAYSIA, AND ITS ASSOCIATION WITH MALIGNANCIES.. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 17(4). A25–A25. 2 indexed citations

11.

Churdboonchart, Vina, et al.. (1991). Antibodies against Dengue Viral Proteins in Primary and Secondary Dengue Hemorrhagic Fever. American Journal of Tropical Medicine and Hygiene. 44(5). 481–493. 91 indexed citations

12.

Churdboonchart, Vina, et al.. (1990). Dengue virus serotypic identification using suckling mouse and western blot technique.. PubMed. 21(4). 614–20. 3 indexed citations

13.

Churdboonchart, Vina, Natth Bhamarapravati, & Sutee Yoksan. (1984). Crossed Immunoelectrophoresis for the Detection of Split Products of the Third Complement Component in Dengue Hemorrhagic Fever. American Journal of Tropical Medicine and Hygiene. 33(6). 1239–1247. 2 indexed citations

14.

Churdboonchart, Vina, Natth Bhamarapravati, & Prasit Futrakul. (1983). Crossed Immunoelectrophoresis for the Detection of Split Products of the Third Complement in Dengue Hemorrhagic Fever. American Journal of Tropical Medicine and Hygiene. 32(3). 569–576. 21 indexed citations

15.

Churdboonchart, Vina, et al.. (1981). Quantitation of dengue precipitating antibody by inhibition countercurrent immunoelectrophoresis. Journal of Clinical Microbiology. 13(3). 401–404. 1 indexed citations

16.

Churdboonchart, Vina, et al.. (1979). Rapid Detection of Dengue Viral Antigens by Counterimmunoelectrophoresis. American Journal of Clinical Pathology. 71(1). 102–108. 1 indexed citations

17.

Churdboonchart, Vina, Valee Harisdangkul, & Natth Bhamarapravati. (1974). COUNTERCURRENT IMMUNOELECTROPHORESIS FOR RAPID DIAGNOSIS OF DENGUE HÆMORRHAGIC FEVER. The Lancet. 304(7884). 841–841. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact